SUSQUEHANNA INTERNATIONAL GROUP, LLP - FENNEC PHARMACEUTICALS INC ownership

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 30 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 2.31 and the average weighting 0.5%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$214,035
-72.6%
28,500
-67.8%
0.00%
Q2 2023$780,828
-63.6%
88,429
-65.7%
0.00%
Q1 2023$2,144,230
-20.2%
257,720
-7.9%
0.00%
Q4 2022$2,687,165
+217.3%
279,913
+167.6%
0.00%
Q3 2022$847,000
-33.7%
104,600
-53.8%
0.00%
Q2 2022$1,278,000
+21.4%
226,175
+20.3%
0.00%
Q1 2022$1,053,000
-41.8%
188,064
-54.2%
0.00%
Q4 2021$1,808,000
+198.8%
410,802
+540.5%
0.00%
Q3 2021$605,000
+62.2%
64,142
+25.5%
0.00%
Q2 2021$373,000
+119.4%
51,098
+124.7%
0.00%
Q4 2020$170,000
-51.6%
22,736
-60.7%
0.00%
Q3 2020$351,000
-76.6%
57,860
-67.8%
0.00%
Q2 2020$1,498,000
+184.8%
179,448
+102.7%
0.00%
Q1 2020$526,000
+42.9%
88,518
+55.9%
0.00%
Q4 2019$368,000
+247.2%
56,776
+157.6%
0.00%
Q3 2019$106,000
-84.5%
22,040
-61.1%
0.00%
Q1 2018$686,00056,7070.00%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 2,433,230$18,128,0008.76%
Solas Capital Management, LLC 800,000$5,960,0004.55%
Southpoint Capital Advisors LP 4,077,214$30,375,0000.53%
683 Capital Management, LLC 1,110,000$8,269,0000.39%
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 40,000$298,0000.26%
Avoro Capital Advisors LLC 1,670,000$12,442,0000.21%
Eventide Asset Management 1,120,000$8,344,0000.13%
Hartford Financial Management Inc. 38,848$289,0000.08%
Granahan Investment Management 394,810$2,941,0000.07%
Planned Solutions, Inc. 800$6,0000.01%
View complete list of FENNEC PHARMACEUTICALS INC shareholders